{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:24:55Z","timestamp":1793805895824,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jocn.2026.112130","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:41:22Z","timestamp":1781246482000},"page":"112130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ki-67 \u2265 13% and Local Failure in WHO grade 2 and 3 Meningiomas: A Single-Institution Cohort Study"],"prefix":"10.1016","volume":"152","author":[{"given":"Anthony Yulin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toren","family":"Ikea-Mario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shray","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.112130_b0005","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2018-2022","volume":"27(Supplement_4):iv1-iv66","author":"Price","year":"2025","journal-title":"Neuro Oncol."},{"issue":"20","key":"10.1016\/j.jocn.2026.112130_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205038","article-title":"Long-Term Follow-Up, Treatment Strategies, Functional Outcome, and Health-Related Quality of Life after Surgery for WHO Grade 2 and 3 Intracranial Meningiomas","volume":"14","author":"Pettersson-Segerlind","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"3","key":"10.1016\/j.jocn.2026.112130_b0015","first-page":"248","article-title":"Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and Outcome","volume":"78","author":"Bertero","year":"2019","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.jocn.2026.112130_b0020","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Central Nervous System Cancers. Version 1.2025. Accessed December 28, 2025. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf."},{"issue":"8","key":"10.1016\/j.jocn.2026.112130_b0025","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.jocn.2026.112130_b0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoncol.2024.5506","article-title":"Molecular testing for the world health organization classification of central nervous system tumors: A review","volume":"11","author":"Horbinski","year":"2025","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.jocn.2026.112130_b0035","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/neuonc\/noae253","article-title":"European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro Oncol."},{"issue":"6","key":"10.1016\/j.jocn.2026.112130_b0040","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3171\/2024.4.JNS232857","article-title":"Optimizing the use of Ki-67 proliferative index as a prognostic biomarker in meningiomas using digital analysis","volume":"141","author":"Thirunavu","year":"2024","journal-title":"J Neurosurg."},{"issue":"5","key":"10.1016\/j.jocn.2026.112130_b0045","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3171\/2025.4.JNS25438","article-title":"Ki-67 in meningioma: distribution and implications","volume":"143","author":"Guo","year":"2025","journal-title":"J Neurosurg."},{"issue":"2","key":"10.1016\/j.jocn.2026.112130_b0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11060-025-05057-2","article-title":"Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival","volume":"174","author":"Shukla","year":"2025","journal-title":"J Neurooncol."},{"issue":"9","key":"10.1016\/j.jocn.2026.112130_b0055","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018644","article-title":"The prognostic role of Ki-67\/MIB-1 in meningioma: A systematic review with meta-analysis","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltimore)."},{"issue":"6","key":"10.1016\/j.jocn.2026.112130_b0060","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.3171\/2023.3.FOCUS2337","article-title":"Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes","volume":"54","author":"Khanna","year":"2023","journal-title":"Neurosurg Focus."},{"issue":"6","key":"10.1016\/j.jocn.2026.112130_b0065","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/neuros\/nyaa226","article-title":"The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma","volume":"87","author":"Mirian","year":"2020","journal-title":"Neurosurgery."},{"issue":"4","key":"10.1016\/j.jocn.2026.112130_b0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3171\/2016.11.JNS16913","article-title":"Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas","volume":"128","author":"Kim","year":"2018","journal-title":"J Neurosurg."},{"key":"10.1016\/j.jocn.2026.112130_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108450","article-title":"Recurrence of atypical and anaplastic intracranial Meningiomas: A meta-analysis of risk factors","volume":"244","author":"Sanikommu","year":"2024","journal-title":"Clin Neurol Neurosurg."},{"issue":"1","key":"10.1016\/j.jocn.2026.112130_b0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11060-023-04537-7","article-title":"Ki-67 labeling index predicts tumor progression patterns and survival in patients with atypical meningiomas following stereotactic radiosurgery","volume":"167","author":"Umekawa","year":"2024","journal-title":"J Neurooncol."},{"issue":"5","key":"10.1016\/j.jocn.2026.112130_b0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/01616412.2021.2022915","article-title":"Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma","volume":"44","author":"Anand","year":"2022","journal-title":"Neurol Res."},{"key":"10.1016\/j.jocn.2026.112130_b0090","doi-asserted-by":"crossref","unstructured":"Choi Y, Lim DH, Yu JI, et al. Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma. Am J Clin Oncol. August 11, 2015. doi:10.1097\/COC.0000000000000224.","DOI":"10.1097\/COC.0000000000000224"},{"issue":"1","key":"10.1016\/j.jocn.2026.112130_b0095","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00701-025-06711-4","article-title":"Histopathologic risk factors for progression of atypical meningioma: a retrospective cohort study evaluating the impact and clinical value of mitotic count and Ki-67","volume":"167","author":"Byun","year":"2025","journal-title":"Acta Neurochir (Wien)."},{"issue":"4","key":"10.1016\/j.jocn.2026.112130_b0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1227\/neu.0000000000003469","article-title":"Evaluating Adjuvant Radiation Therapy for Grade 2 Meningioma: A Multi-Institutional Analysis","volume":"97","author":"Gupta","year":"2025","journal-title":"Neurosurgery."},{"issue":"9","key":"10.1016\/j.jocn.2026.112130_b0105","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1470-2045(16)30321-7","article-title":"EANO guidelines for the diagnosis and treatment of meningiomas","volume":"17","author":"Goldbrunner","year":"2016","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.jocn.2026.112130_b0110","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/hupa.2001.27119","article-title":"Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas","volume":"32","author":"Amatya","year":"2001","journal-title":"Hum Pathol."},{"issue":"9420","key":"10.1016\/j.jocn.2026.112130_b0115","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","volume":"363","author":"Whittle","year":"2004","journal-title":"Meningiomas. Lancet."},{"issue":"3","key":"10.1016\/j.jocn.2026.112130_b0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ki.2009.171","article-title":"Diagnostic methods 2: receiver operating characteristic (ROC) curves","volume":"76","author":"Tripepi","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.jocn.2026.112130_b0125","first-page":"380","article-title":"The cancer imaging phenomics toolkit (captk): technical overview","volume":"11993","author":"Pati","year":"2020","journal-title":"Brainlesion."},{"issue":"1","key":"10.1016\/j.jocn.2026.112130_b0130","article-title":"Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome","volume":"5","author":"Davatzikos","year":"2018","journal-title":"J Med Imaging (Bellingham)."},{"issue":"1","key":"10.1016\/j.jocn.2026.112130_b0135","first-page":"132","article-title":"Morphometric and Ki-67 proliferative index-related characteristics of meningiomas and their correlation with demographic, clinical, histopathological, and postoperative features","volume":"21","author":"Pugonja","year":"2023","journal-title":"Med Glas (Zenica)."},{"issue":"11","key":"10.1016\/j.jocn.2026.112130_b0140","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00701-017-3277-y","article-title":"Correlation of volumetric growth and histological grade in 50 meningiomas","volume":"159","author":"Soon","year":"2017","journal-title":"Acta Neurochir (Wien)."},{"issue":"2","key":"10.1016\/j.jocn.2026.112130_b0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3171\/2019.10.JNS192466","article-title":"Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection","volume":"134","author":"Materi","year":"2021","journal-title":"J Neurosurg."},{"issue":"5","key":"10.1016\/j.jocn.2026.112130_b0150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/neuonc\/not325","article-title":"Proposal for a new risk stratification classification for meningioma based on patient age, WHO tumor grade, size, localization, and karyotype","volume":"16","author":"Domingues","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.jocn.2026.112130_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2025.123858","article-title":"Radiotherapy for world health organization grade 1 and 2 intracranial meningiomas: A retrospective analysis of efficacy","volume":"197","author":"Klungtvedt","year":"2025","journal-title":"World Neurosurg."},{"issue":"8","key":"10.1016\/j.jocn.2026.112130_b0160","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00701-019-03966-6","article-title":"Volumetric assessment of glioblastoma and its predictive value for survival","volume":"161","author":"Henker","year":"2019","journal-title":"Acta Neurochir (Wien)."},{"issue":"2","key":"10.1016\/j.jocn.2026.112130_b0165","first-page":"443","article-title":"Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy","volume":"130","author":"Chen","year":"2018","journal-title":"J Neurosurg."},{"issue":"3","key":"10.1016\/j.jocn.2026.112130_b0170","doi-asserted-by":"crossref","DOI":"10.1111\/nan.70018","article-title":"Testing Meningiomas With Methylation Arrays: Insights and Recommendations From a Large Single-Centre Study","volume":"51","author":"Ruiz","year":"2025","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"34","key":"10.1016\/j.jocn.2026.112130_b0175","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol."},{"issue":"12","key":"10.1016\/j.jocn.2026.112130_b0180","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(06)70625-1","article-title":"Histological classification and molecular genetics of meningiomas","volume":"5","author":"Riemenschneider","year":"2006","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jocn.2026.112130_b0185","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","article-title":"High-risk Meningioma: Initial Outcomes From NRG Oncology\/RTOG 0539","volume":"106","author":"Rogers","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys."}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682600281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682600281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T14:24:53Z","timestamp":1793802293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758682600281X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S096758682600281X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112130","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ki-67 \u2265 13% and Local Failure in WHO grade 2 and 3 Meningiomas: A Single-Institution Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112130"}}